Researchers found that an NHS test for ovarian cancer in premenopausal women performs poorly, with ultrasound‑based methods demonstrating increased accuracy.

A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

Ovarian cancer has the lowest survival rate of any women's cancer, killing roughly one thousand women in Australia every year. But now, there's a new blood test that offers hope for detection, and ...

For women, ovarian cancer is one of the most feared of all diagnoses. Sneaking up silently, often with few symptoms, the ...

Sept. 12 -- FRIDAY, Sept. 11 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new test for women with pelvic tumors that are known to need surgery. The test, called OVA1, will ...

Only 23.3% of ovarian cancer patients receive BRCA testing, leading to higher treatment costs and advanced therapy lines. Non-White and low-income patients face increased financial toxicity, ...

June 14, 2010 — The US Food and Drug Administration (FDA) has cleared a chemiluminescent microparticle immunoassay (Architect human epididymis protein 4 [HE4] assay; Abbott Diagnostics) for the ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Women with an inherited risk of developing ovarian cancer because they have the so-called Angelina Jolie gene alteration can now be tested on the NHS thanks to UCL research. University College London ...

Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying the women more likely to respond to an ovarian cancer treatment known as PARP inhibitor ...